Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the optimal duration of anticoagulation therapy (3
months versus 12 months) with direct oral anticoagulant (edoxaban) for isolated distal deep
vein thrombosis.